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A VapBC Toxin-Antitoxin Module Is a Posttranscriptional Regulator
of Metabolic Flux in Mycobacteria
Joanna L. McKenzie,a Jennifer Robson,b Michael Berney,b Tony C. Smith,c Alaine Ruthe,a Paul P. Gardner,d Vickery L. Arcus,a
and Gregory M. Cookb
Department of Biological Sciences, University of Waikato, Hamilton, New Zealanda; Department of Microbiology and Immunology, Otago School of Medical Sciences,
University of Otago, Dunedin, New Zealandb; Department of Computer Science, University of Waikato, Hamilton, New Zealandc; and School of Biological Sciences,
University of Canterbury, Christchurch, New Zealandd
The largest family of toxin-antitoxin (TA) modules are encoded by the vapBC operons, but their roles in bacterial physiology
remain enigmatic. Microarray analysis in Mycobacterium smegmatis overexpressing VapC/VapBC revealed a high percentage of
downregulated genes with annotated roles in carbon transport and metabolism, suggesting that VapC was targeting specific met-
abolic mRNA transcripts. To validate this hypothesis, purified VapC was used to identify the RNA cleavage site in vitro. VapC
had RNase activity that was sequence specific, cleaving single-stranded RNA substrates at AUAU and AUAA in vitro and in vivo
(viz., MSMEG_2121 to MSMEG_2124). A bioinformatic analysis of these regions suggested that an RNA hairpin 3= of the
AUA(U/A) motif is also required for efficient cleavage. VapC-mediated regulation in vivo was demonstrated by showing that
MSMEG_2124 (dhaF) and MSMEG_2121 (dhaM) were upregulated in a vapBC mutant growing on glycerol. The vapBC mu-
tant had a specific rate of glycerol consumption that was 2.4-fold higher than that of the wild type during exponential growth.
This increased rate of glycerol consumption was not used for generating bacterial biomass, suggesting that metabolism by the
vapBC mutant was uncoupled from growth. These data suggest a model in which VapC regulates the rate of glycerol utilization
to match the anabolic demands of the cell, allowing for fine-tuning of the catabolic rate at a posttranscriptional level.
Bacterial toxin-antitoxin (TA) modules were first reported asfactors that protect low-copy-number plasmids in bacteria
from postsegregational loss (35). This mechanism of protection is
achieved through the production of a stable toxin and an unstable,
cognate antitoxin. If the plasmid-borne TA operon is lost from a
bacterial cell, the toxin persists and kills the plasmid-free cell.
Since this initial report, TA operons have been shown to be wide-
spread and found in nearly every sequenced bacterial and archaeal
genome. The presence of TA operons on bacterial chromosomes
suggests that these modules may play additional roles other than
protection of mobile DNA. For example, TA modules have been
shown to be associated with antibiotic resistance/tolerance, viru-
lence and pathogenicity islands, bacterial persistence, and patho-
gen trafficking (26, 30, 31, 43).
TA modules have been classified into three types according to
the molecular identity of each component (25). For type I mod-
ules, the antitoxin is a small antisense RNA molecule that prevents
toxin translation. Type II modules encode a protein antitoxin that
binds its cognate toxin and inhibits its activity. Type III TA mod-
ules encode a protein toxin and an RNA antitoxin that interact
and form a protein-RNA complex. These types are further subdi-
vided into nine families, and coincidentally, nine potential biolog-
ical functions for toxin-antitoxin modules have been proposed
(41). The toxic components of the TA modules exert their effects
in different ways. The CcdB and ParE toxins are DNA gyrase in-
hibitors; the RelE, Doc, and HigB toxins directly or indirectly
cleave ribosome-associated mRNAs; HipA is a protein kinase that
targets EF-Tu; and the VapC and MazF families are families of
RNases that cleave mRNA transcripts independently of the ribo-
some (25). The VapC and MazF toxins have been collectively de-
scribed as mRNA interferases whose biochemical activity results
in the inhibition of translation (34, 51). Bacteria often harbor
more than one type of TA module, and it remains to be deter-
mined whether these systems interact to regulate whole-cell phys-
iology.
The most prevalent TA modules in bacteria and archaea are the
VapBC family, and the distribution of vapBC operons across spe-
cies is intriguing. In many sequenced genomes, there are between
one and five copies of vapBC TAs. However, in several unrelated
organisms, the vapBC family of TAs is greatly expanded in num-
ber. For example, the genome of the important human pathogen
Mycobacterium tuberculosis harbors 45 putative vapBC operons (3,
4, 50), and the unrelated archaeon Pyrococcus kodakaraensis con-
tains 29 putative vapBC operons (54). Strikingly, among the my-
cobacteria, this expansion of toxin-antitoxin operons is confined
to just the mammalian pathogens M. tuberculosis and M. bovis. In
contrast, Mycobacterium smegmatis and Mycobacterium avium
subsp. paratuberculosis have a single vapBC TA operon, and M.
leprae has none (4). The role of VapBC in the biology of mycobac-
teria remains unknown. VapBC modules have been implicated in
controlling bacterial growth in the intracellular environment (33)
and regulating rates of nitrogen fixation and biomass production
during symbiosis in a host plant (8). VapC from the enteric bac-
teria Shigella flexneri 2a and Salmonella enterica has been shown to
cleave tRNAfMet in the anticodon stem-loop in a heterologous
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host, thus inhibiting translation (62). Overexpression of VapC in
a vapBC mutant of M. smegmatis caused growth inhibition via
disruption of translation, and this effect was most pronounced in
rapidly growing cells (i.e., early exponential phase) (51). Interest-
ingly, the phenotype was reversible in the vapBC mutant, which
suggests that the antitoxin was not required for reversing the bac-
teriostasis and that M. smegmatis may use the VapBC module to
trigger a reversible bacteriostasis under conditions where the cell’s
carbon metabolism is not coupled to growth due to other imbal-
ances (e.g., nitrogen limitation) (51). Using a regulator of protein
synthesis (i.e., an RNase) to control metabolic activity when re-
quired would seem advantageous when one considers that 70 to
90% of cellular ATP consumption is used for protein synthesis
(12).
To address the hypothesis of catabolic and anabolic regulation
(51), we measured the genome-wide transcriptional response to
VapC overexpression (in comparison to VapBC overexpression)
and identified a cohort of genes specifically targeted by VapC
(operons for sugar transport). Using purified VapC and RNase
assays, we have identified the cut site of VapC in these sugar trans-
port operons, confirming our microarray data. In a vapBC mu-
tant, the specific rate of glycerol consumption was greater than
that needed for growth, and therefore, metabolism appeared to be
uncoupled from anabolic reactions and metabolic demand. These
data support a model for VapC controlling the balance of cata-
bolic and anabolic reactions in the mycobacterial cell to optimize
cellular metabolism.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. Bacterial strains and
plasmids used in this study are listed in Table 1. Escherichia coli strains for
plasmid preparation were grown in Luria-Bertani (LB) medium supple-
mented with the appropriate antibiotic for plasmid selection. Mycobacte-
rium smegmatis strain mc2155 (56) and vapBC deletion strain (JR121)
(51) were grown in LB supplemented with 0.05% (wt/vol) Tween 80
(LBT) and Hartmans de Bont (HdB) (55) minimal medium supple-
mented with 0.2% glycerol and 0.05% (wt/vol) Tween 80. All M. smegma-
tis cultures used in growth experiments, for harvesting RNA, and for use
in biochemical assays were set up as follows. For initial starter cultures,
strains were inoculated into LBT, grown overnight to an optical density at
600 nm (OD600) of below 0.4, and then placed at 4°C. A second starter
culture was then inoculated (OD600 of 0.005) from the LBT overnight
cultures into appropriate growth medium to be used in the final experi-
ment. This was done to ensure that an optical density (OD600 of 0.2)
associated with early-exponential-phase cells would be achieved of this
second starter for direct use. The second starter was used to inoculate
flasks containing HdB or LBT medium to an OD600 of 0.0025 for use in
experiments. All strains were grown at 37°C with agitation (200 rpm). The
OD600 was measured in a Jenway 6300 spectrophotometer. Strains har-
boring pMind constructs were inoculated into appropriate medium con-
taining hygromycin B (50 g ml1). For complementation of growth
experiments, tetracycline (20 ng ml1) was included in all media to ensure
that expression occurred upon inoculation of cultures. For microarray
analysis, vapBC deletion mutant strain JR121 was used harboring tetra-
cycline-inducible expression constructs pMind_vapC and pMind_vapBC
for overexpression of toxin VapC and toxin-antitoxin complex VapBC as
previously published (51). Western blot analysis was used to detect the
levels of VapC protein using VapC polyclonal antibodies as previously
described (51).
Cell harvest of batch cultures for RNA extraction. For use in mi-
croarray analysis, M. smegmatis JR121 harboring pMind-vapBC (pJR230)
and pMind-vapC (pJR29) were grown in a 400-ml volume of HdB in a
2-liter flask. Cultures were grown to an OD600 of 0.1, and protein ex-
pression was then induced with tetracycline (20 ng ml1). Cells were
harvested 60 min postinduction by using a cold-glycerol-saline quenching
method described previously (6, 61). Four independent experiments were
performed. For gene expression analysis comparing mRNA from the
vapBC mutant and the wild-type mc2155 strain, cultures were grown in
a 200-ml volume of HdB to an OD600 of 0.1 before harvesting with
glycerol-saline solution.
For extraction of total RNA for microarray and quantitative real-time
PCR (qRT-PCR), cells were resuspended in TRIzol reagent (Invitrogen),
and RNA was extracted according to the manufacturer’s instructions. The
RNA was resuspended in water containing 0.1% diethyl pyrocarbonate
(DEPC)–Milli-Q and incubated at 55°C for 10 min. To remove any con-
taminating DNA present in samples, extracted RNA was treated with 2 U
of RNase-free DNase using a Turbo RNase-free kit (Ambion) according to
the manufacturer’s instructions. Alternatively, for total RNA extraction
required for use in reverse transcriptase PCR of the 5= untranslated region
(5=UTR) of MSMEG_2124, cells were resuspended in 5 M guanidinium
isothiocyanate (GITC) (pH 7), pelleted by centrifugation, resuspended in
0.5 ml fresh GITC, and transferred to a new tube containing approxi-
mately 0.3 g of 0.1-mm and 2.5-mm zirconia beads. Beads were mixed in
a Fastprep FP120 bead beater (Thermosavant) for 20 s and left to cool for
1 min, and the process was repeated 3 times for increasing periods (i.e., 20,
25, 30, and 30 s). The supernatant was removed, and nucleic acids were
twice extracted with phenol-chloroform followed by isopropanol precip-
itation. The precipitated RNA was washed with 70% ethanol and resus-
pended in 25 l of 10 mM Tris-HCl (pH 7.0) and 0.5 mM MnCl2. The
extracted RNA was DNase treated by the addition of 1 l DNase (Pro-
mega) per g RNA present and incubated at 37°C for 30 min with shaking
at 600 rpm. The DNase reaction was stopped by the addition of EGTA stop
TABLE 1 Bacterial strains and plasmids used in this study
Bacterial strain or plasmid Relevant genotype or phenotype or descriptiona Source or reference
E. coli DH5 fhuA2 (argF-lacZ)U169 phoA glnV44 80 (lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 Stratagene
M. smegmatis
mc2155 Electrocompetent wild-type strain of M. smegmatis 56
JR121 mc2155 vapBC::aphA-3; Kmr 51
Plasmids
pDEST17 Gateway expression vector for M. smegmatis; Hygr Lab stock
pcDNA3 Mammalian expression vector; Apr Invitrogen
pGEM-T Easy Cloning vector; Apr Promega
pJR29 pMind harboring vapC with synthetic RBS from kanamycin marker; Kmr Hygr 51
pJR230 pMind harboring vapBC with synthetic RBS from kanamycin marker; Kmr Hygr 51
a RBS, ribosome binding site.
McKenzie et al.
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solution and heated to 65°C for 10 min. All RNA concentrations were
determined using a Nanodrop ND-1000 spectrophotometer, and RNA
integrity was analyzed by agarose gel electrophoresis. RNA samples were
stored at 80°C.
Microarray analysis and quantitative real-time PCR. Microarray
analysis was performed as previously described (6). Synthesis of cDNA
and aminoallyl-dUTP (aa-dUTP) labeling was performed using protocol
standard operating procedure (SOP) M007 provided by the Pathogen
Functional Genomics Research Center (PFGRC) (http://pfgrc.jcvi.org)
established by the National Institute of Allergy and Infectious Diseases
(NIAID) and the J. Craig Venter Institute (JCVI). Cy dye-labeled cDNA
probes were hybridized to microarray slides supplied by the PFGRC
funded by NIAID using protocol SOP M008 provided by the PFGRC.
Slides were scanned in a Genepix 4000A scanner at a 10-m pixel size and
autoadjusted photomultiplier gain, and data analysis was performed as
previously described (6). All data have been deposited at the Gene Expres-
sion Omnibus (GEO, NCBI) under accession number GSE29631. qRT-
PCR was performed to validate gene expression changes detected by mi-
croarray analysis and detect mRNA differences between the wild-type
mc2155 and vapBC mutant strain. The sequences of selected genes were
retrieved from the JCVI/Comprehensive Microbial Resource (CMR) da-
tabase (http://cmr.jcvi.org) for primer design, which was performed using
Primer3 (version 0.4.0) (http://frodo.wi.mit.edu/primer3/) or Primer Ex-
press software v3.0 (Applied Biosystems). All primers were optimized to
determine optimal primer concentration. All oligonucleotides used in this
study are listed in Table S1 in the supplemental material and labeled
MSMEG_XXXX (gene identification [ID] number) followed by the letter
M for use in microarray validation or Q for use in qRT-PCR for the
vapBC mutant and strain mc2155. For qRT-PCR, total RNA (1 g) was
obtained and reverse transcribed with random primers (250 ng) and
SuperScript III reverse transcriptase (both from Invitrogen) according to
the manufacturer’s instructions. Quantitative real-time PCR was per-
formed according to the manufacturer’s instructions with Platinum SYBR
Green qPCR SuperMix-UDG with ROX (Invitrogen) using an ABI Prism
7500 (Applied Biosystems). The qRT-PCR cycle included stage I (1 step of
2 min at 95°C), stage II (40 cycles, with 1 cycle consisting of 15 s at 95°C
and 1 min at 60°C), followed by stage III dissociation step (1 cycle con-
sisting of 15 s at 95°C, 1 min at 60°C, 15 s at 95°C, and 15 s at 60°C).
Relative gene expression was determined from calculated threshold cycle
(CT) values using sigA gene (MSMEG_2758) as an internal normalization
standard. Expression ratios were subjected to a two-tailed paired t test
(VapC/VapBC) or unpaired t test (vapBC/mc2155) to determine statis-
tical significance.
Reverse transcriptase PCR for determination of MSMEG_2124
5=UTR. Total RNA was reverse transcribed using SuperScript III reverse
transcriptase (RT) (Invitrogen, USA) with random hexamers. Briefly, 1
g DNase-treated RNA was incubated with a total of 100 ng random
primer oligonucleotides (Invitrogen) at 65°C for 5 min and then cooled
for 1 min on ice, followed by the addition of 4 l of 5 buffer (250 mM
Tris-HCl, pH 8.3, containing 375 mM KCl and 15 mM MgCl2), 1 l
dithiothreitol (DTT), 1 l of 10 mM deoxynucleoside triphosphates
(dNTPs), and 0.7 l SuperScript III RT. The reaction was performed at
25°C for 10 min, 50°C for 1 h, and 85°C for 10 min. For each sample, a
negative RT-PCR (no reverse transcriptase added) was performed and
used as a negative control in subsequent PCRs. Genomic DNA and cDNA
were used as the templates in traditional PCRs utilizing Taq DNA poly-
merase (Invitrogen) and gene (transcript)-specific primers. Two primer
sets were used. Primers MSMEG_2124 RT Rev (Rev stands for reverse)
and MSMEG_2124 RT Fwd (Fwd stands for forward) were used to verify
the annotated MSMEG_2124 gene, and primers MSMEG_2124 (RT) Rev
and MSMEG_2124 77-98 RT Fwd were used to determine whether the
5=UTR included up to 98 bp upstream of MSMEG_2124. cDNA or
genomic DNA (gDNA) (2.5 l) was added to a final concentration of
around 37.5 ng per 25-l PCR mixture. The PCR conditions were as
follows: (i) an initial denaturation step at 95°C for 5 min; (ii) 39 cycles,
with 1 cycle consisting of 30 s at 95°C, 30 s at 65 to 69°C, 55 s at 72°C, and
30 s at 95°C; (iii) a final extension step of 68°C for 7 min. PCR products
were analyzed by agarose gel electrophoresis.
Tryptic digestion of the VapBC complex and purification of VapC
from M. smegmatis. The VapBC complex from M. smegmatis was puri-
fied by the method of Robson et al. (51) and digested with 0.1 mg ml1
trypsin (Sigma-Aldrich) for 60 min at room temperature. Reactions were
stopped by the addition of 0.1 mg ml1 trypsin inhibitor from Glycine
max (soybean) (Sigma-Aldrich) and incubated for 15 min at room tem-
perature. Trypsin digestion products of the purified VapBC complex in-
hibited with trypsin inhibitor were dialyzed against 50 mM phosphate
buffer (pH 7.4) and 100 mM NaCl overnight and subjected to anion-
exchange chromatography to separate the trypsin plus inhibitor from
VapC. The trypsin digestion products were loaded onto a 5-ml HiTrap Q
anion-exchange column (GE Healthcare) and washed with 25 ml of 50
mM phosphate buffer (pH 7.4) and 100 mM NaCl at a flow rate of 1 ml
min1 to remove the trypsin. Bound proteins were removed by running a
gradient of 0 to 100% (vol/vol) elution buffer (50 mM phosphate buffer
[pH 7.4], 1 M NaCl) over 50 ml at a flow rate of 1 ml · min1. Fractions
containing the desired protein were then analyzed by SDS-PAGE. VapC
was further purified by size exclusion chromatography. VapC was ana-
lyzed on an analytical S75 10/300 gel filtration column (GE Healthcare,
United Kingdom), and fractions containing VapC protein were analyzed
by SDS-PAGE.
Transcription of pentaprobe RNA. The pentaprobe pack was ob-
tained from Joel McKay, School of Molecular Bioscience, University of
Sydney, Australia, and consists of 12 plasmids (38). This included both
forward (A922 to A227) and reverse (A928 to A933) pentaprobe strands
under a T7 promoter. A922 is complementary to A928, A923 is comple-
mentary to A929, and so on. Plasmids were transformed into electrocom-
petent E. coli DH5 cells. Successful transformants were cultured in LB
broth including 50 g ml1 ampicillin, and the plasmid was extracted
using the Qiagen miniprep kit according to the manufacturer’s instruc-
tions. Primers for amplification of the pentaprobe insert were designed to
flank the T7 promoter in pcDNA3 (pcDNA3 PP Fwd [PP stands for pen-
taprobe]) and the end of the pentaprobe insert (pcDNA3 PP Rev). The
pentaprobe insert was PCR amplified using the Pfx DNA polymerase sys-
tem (Invitrogen) and gel purified. DNA concentrations were determined
using a Nanodrop ND-1000 spectrophotometer. RNA was transcribed
from 800 ng of the pentaprobe PCR product using the T7 MEGAscript kit
(Ambion) according to the manufacturer’s instructions. Transcribed
RNA was purified by sodium acetate and ethanol precipitation and resus-
pended in nuclease-free water. RNA concentrations were determined us-
ing a Nanodrop ND-1000 spectrophotometer, and the secondary struc-
ture of RNA molecules was predicted using RNAstructure version 4.6
(42).
Primers were designed for the amplification of 50 bases on either side
of the ATA(A/T) cut site in the 932 pentaprobe RNA. The 100-bp frag-
ment (termed 932 50-150) was PCR amplified, gel purified, and then used
as a template in a further PCR with the same reverse primer (932 150 Rev)
as described above and a forward primer including a T7 promoter (T7 932
50 Fwd). The DNA concentration of the template was determined, and
RNA was transcribed and purified as described above. Single-stranded
pentaprobe RNA was annealed with its reverse complement RNA strand
(i.e., 927 with 933) to form double-stranded RNA (dsRNA). Equal molar
ratios of each strand were combined with nuclease-free water, heated to
70°C for 15 min, and then cooled slowly to room temperature. Annealed
RNA was run on an agarose gel and stained with acridine orange to dis-
tinguish between double- and single-stranded RNA. Double-stranded
nucleic acids stain bright fluorescent green, whereas single-stranded nu-
cleic acids stain bright reddish-orange. A single strand of pentaprobe
DNA was amplified by asymmetric PCR from the template pentaprobe
PCR product using the Pfx DNA polymerase system (Invitrogen). How-
ever, 1:50 and 1:100 reverse/forward primer ratios were used instead of 1:1
ratios, and 35 cycles were employed to increase amplification. The PCR
VapBC Regulates Metabolic Flux
May 2012 Volume 194 Number 9 jb.asm.org 2191







products were analyzed by agarose gel electrophoresis and staining with
acridine orange, and single-stranded DNA products were gel purified.
VapC RNase activity assay. Mycobacterium smegmatis VapC RNase
activity assay mixtures contained 1 g purified VapC protein for pen-
taprobe assays and 0.02 g purified VapC for M. smegmatis transcript
assays, 1 g purified RNA (molar ratios of VapC to RNA varied from 5:1
to 1:1), 12 mM phosphate buffer (sodium phosphate typically used except
for matrix-assisted laser desorption ionization mass spectrometry
[MALDI MS] when ammonium phosphate was used), 6 mM NaCl, and 6
mM MgCl2. The MgCl2 concentrations used in this study are consistent
with previously reported studies (5, 44, 62). Individual assay reaction
mixtures were set up for each time point to reduce the possibility of RNase
contamination. Negative controls included RNA-only reaction mixtures
(no VapC added) or reaction mixtures with 12 mM EDTA added or with
VapBC complex added instead of VapC. Assay mixtures were incubated at
37°C, and time point reactions were stopped by the addition of 10 l
formamide loading dye, or for analysis by mass spectrometry, assay mix-
tures were heat inactivated by incubating at 70°C for 10 min followed by
the addition of ammonium acetate and ethanol for precipitation of RNA.
Design of 932 RNA oligonucleotides and cut-site analysis by MALDI
MS. RNA oligonucleotides were designed to cover bases 54 to 242 of
pentaprobe 932. Nine overlapping oligonucleotides (932 RNA oligonu-
cleotides 1 to 9) of 30 to 36 bases were designed to cover the 188-base RNA
segment. RNAstructure version 4.6 was used to predict secondary struc-
ture, and the short oligonucleotides were designed to mimic these regions
of the whole 932 pentaprobe RNA molecule. RNA oligonucleotide assays
were precipitated to remove contaminants by the addition of ammonium
acetate (final concentration of 5 M) (pH 5.2) and three times the volume
of 100% ethanol. The samples were precipitated on ice for 30 min, centri-
fuged at 13,000  g for 20 min at 4°C, then washed with 70% (vol/vol)
ethanol, and centrifuged as described above. The supernatant was then
removed, and the RNA pellet was resuspended in nuclease-free water and
stored at 80°C. Matrix for MALDI MS of RNA oligonucleotides was
prepared fresh daily. The matrix solution consisted of 5 mg of 3-hy-
droxypicolinic acid (3-HPA), 10 l of 2.5 M diammonium citrate, 125 l
of acetonitrile (ACN), and 365 l of DEPC water. The solution was vor-
texed well until all matrix dissolved and then centrifuged for 5 min at
13,000  g. A 1-l aliquot of matrix solution was spotted onto either an
Anchorchip or stainless steel target plate (Bruker Daltonics) and left to air
dry. A 1-l sample and 1 l of the oligonucleotide calibration standard
(Bruker Daltonics) were spotted onto the dried matrix and left to air dry.
An Autoflex II MALDI–time of flight (MALDI-TOF) mass spectrom-
eter (Bruker Daltonics) was used to analyze samples. The samples were
analyzed in linear mode, with the mass range selector set at “low range,”
pulsed ion extraction of 150 ns, gain to 2,500 V, acceleration voltage to 20
kV, and a range of 2 to 12 kDa was collected. Laser power was typically
around 60%. The spectra for the oligonucleotide calibration standard
(Bruker Daltonics) were collected first, and the spectrometer was cali-
brated with an automatic polynomial correction. The spectra were saved
and exported to DataAnalysis software (Bruker Daltonics) where the
baseline was subtracted and peaks were identified and labeled. The online
tool Mongo Oligo Mass Calculator version 2.06 (52) was used to deter-
mine theoretical masses of RNA oligonucleotide fragments to compare to
masses from obtained spectra. The Mongo Oligo Mass Calculator allowed
the addition of 5= and 3= modifications to the RNA oligonucleotide.
Transcription of MSMEG_2124, MSMEG_2123, MSMEG_2122,
MSMEG_2121, MSMEG_0650, and MSMEG_1965. The gene encoding
MSMEG_2124 was PCR amplified to include the 5=UTR. MSMEG_2124
plus 150 bp upstream was cloned using primers MS_2124 T7 pGem F and
R [F stands for forward, and R stands for reverse]) was cloned into
pGEM-T Easy Vector system (Promega) using the 3=-T overhang. The
resulting plasmid was sequence verified and used as a DNA template in
subsequent PCRs. The Pfx DNA polymerase system (Invitrogen) and
pUC/M13 primers were used to amplify MSMEG_2124 plus the 5=UTR
from pGEM_MS2124 to include the T7 promoter. PCR products were gel
purified, and the DNA concentration was determined using a Nanodrop
ND-1000 spectrophotometer.
Primers for amplification of genes in the annotated MSMEG_2124
operon and MSMEG_1965 (tRNA fMet) were designed to flank either end
of the gene (termed MSMEG_XXXX RNA F and MSMEG_XXXX RNA R
in Table S1 in the supplemental material). MSMEG_2124 (no 5=UTR),
MSMEG_2123, MSMEG_2122, MSMEG_2121, and MSMEG_1965 genes
were PCR amplified from M. smegmatis mc2155 genomic DNA using the
Pfx DNA polymerase system (Invitrogen) and gel purified. A further
round of PCR amplification using the purified MSMEG_2124, -2123,
-2122, -2121, and -1965 PCR products and a forward primer including the
T7 RNA polymerase promoter site (termed MSMEG_XXXX RNA T7 F in
Table S1) was performed to add the T7 promoter site immediately up-
stream of the gene sequence for use in subsequent transcription reactions.
MSMEG_0650 was amplified from pDEST-MSMEG_0650 (a kind gift
from Shaun Lott, Department of Structural Biology, University of Auck-
land) using T7 forward and reverse primers and the Pfx DNA polymerase
system (Invitrogen). The gel-purified PCR product was used as the tem-
plate in subsequent transcription reactions. Oligonucleotide sequences
can be found in Table S1. DNA concentrations were determined using a
Nanodrop ND-1000 spectrophotometer. PCR products were sequenced
using a T7 primer to ensure fidelity for RNA transcription.
RNA was transcribed from 800 ng of the PCR product using the T7
MEGAscript kit (Ambion) according to the manufacturer’s instructions.
Transcribed RNA was purified by sodium acetate and ethanol precipita-
tion and resuspended in nuclease-free water. RNA concentrations were
determined using a Nanodrop ND-1000 spectrophotometer, and the sec-
ondary structures of RNA molecules were predicted using RNAstructure
version 4.6 (42).
RNA bioinformatics. We employed a local minimum-free energy ap-
proach to RNA structure prediction that has been proven to work well in
longer sequences (32). This was implemented in the RNALfold algorithm
that forms part of the Vienna RNA package. This implementation returns
a Z-score for structures that are significantly more stable than expected
given their length and nucleotide composition (63). Initial predictions
used RNALfold on the three positive exemplars for VapC cleavage (MS-
MEG_2121, MSMEG_2124 5=UTR, and pentaprobe 932). All three pre-
dictions conformed to the same basic structure: a 5= AUA(U/A) motif
followed by a stable hairpin. Given that the three experimentally charac-
terized VapC cleavage targets appeared to share a basic secondary struc-
ture, it was possible to build a sequence alignment and consensus second-
ary structure based on these three substrates. From this, we built a
covariance model (CM), which was used for predicting homologous and
analogous structures in other sequences (17, 18, 45, 46). The CM was used
to search 60 operons and flanking sequences that contained at least one of
the 106 genes downregulated by VapC for analogous motifs. The high-
scoring matches to this CM were then incorporated into the alignment.
The alignment and consensus secondary structure were manually refined,
and the CM was then rebuilt and researched against the 60 operons. This
process was iterated for several cycles until no further high-scoring
matches were found. The CM was then used to search the genome of M.
smegmatis.
Molar growth yields and biochemical assays. Glycerol utilization and
dry weights were measured to calculate molar growth yield on glycerol
(Yglycerol) (in grams [dry weight] of cells per mole of glycerol consumed)
and glycerol consumption (in millimoles of glycerol/h/g [dry weight] of
cells). Cultures were grown in HdB. Supernatant samples were taken after
the initial inoculation to determine the starting glycerol concentration of
each individual flask and at specified time points during growth. All cul-
ture samples were centrifuged (5 min, 13,000 rpm) to obtain cell-free
supernatant for use in glycerol assay and stored at 20°C. Glycerol con-
centration was measured by detecting NADH oxidation (absorbance at
340 nm) using previously published methods (49). Briefly, a working
solution of assay mix contained 0.5 U ml1 glycerokinase from E. coli
(Sigma-Aldrich), 0.5 U ml1 pyruvate kinase from rabbit muscle (Sigma-
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Aldrich), 1 U ml1 lactic dehydrogenase from rabbit muscle (Roche), 50
mM Tris HCl (pH 8), 2 mM MgCl2, 0.25 mM NADH, 3 mM phosphoe-
nolpyruvate (PEP), and 3 mM ATP. A standard curve was analyzed with
each set of supernatant samples, which was prepared from 10 mM glycerol
stock. The reaction mixtures were incubated in microcentrifuge tubes for
15 min at 37°C to allow the enzyme assay to reach an endpoint. For the cell
weight (dry weight) of each time point, 20 ml of culture was harvested in
triplicate by filtration (0.22 m; Millipore), and filters were dried at 65°C
until the same weight (dry weight) was achieved on consecutive days. The
growth rate for the log phase of growth was determined by plotting the
log10 of the optical density against time. Biological replicates were per-
formed 2 or 3 times for each time point.
RESULTS
VapC overexpression downregulates a large cohort of genes in-
volved in carbon transport and metabolism. To gain molecular
insight into the role of VapC-mediated inhibition of cell growth
(51), the transcriptional response of M. smegmatis to the condi-
tional overexpression of VapC was assessed through microarray
analysis. Microarray analysis was performed using vapBC dele-
tion strains expressing VapC and VapBC to ensure that the only
changes in gene expression would be in response to the presence of
the toxin compared with expression of the inactive VapBC com-
plex. As growth inhibition generally occurs during overexpression
of toxin components of TA systems, it was important to preempt
this inhibitory effect in order to identify the transcriptional re-
sponse to VapC (RNase activity) and not a general response asso-
ciated with inhibition of cell growth and/or general cell stress. A
time course experiment was performed to determine the level of
VapC expression after induction with tetracycline. Western blot-
ting confirmed VapC expression at the time (60 min) of RNA
sampling (Fig. 1A). This level of VapC expression was in good
agreement with overexpressed VapBC in the same genetic back-
ground (51). Under the conditions of VapC and VapBC expres-
sion, no difference in the growth rate between the strains express-
ing VapC and VapBC was observed at 60 min (time of RNA
harvest for microarray studies).
Comparison of the transcriptional response of the vapBC
strain expressing VapC with that of the same strain expressing
VapBC identified a total of 205 genes exhibiting a 1.50-fold or
greater change in expression (P  0.05, four biological repeats
including two dye swaps). This represents an altered expression of
2.86% of the M. smegmatis genome (total 6,933 genes) (see Table
S2 in the supplemental material). Of these differentially expressed
genes, 106 genes were downregulated and 99 were upregulated in
response to VapC (Table S2). In order to analyze the data, genes
were assigned to categories that had previously been used to deci-
pher the genome sequence of Mycobacterium tuberculosis and were
based on putative functions of the encoded proteins (10). The
microarray data were validated by qRT-PCR analysis of 9 selected
genes (Fig. 1B). In response to VapC, 34% of the gene transcripts
that were downregulated (1.50-fold) were predicted to be in-
volved in the transport and catabolism of carbohydrate sources
(Table 2). The majority of these downregulated gene transcripts
are organized in operons with other genes that also exhibited
downregulation (18 genes are involved in carbohydrate transport,
and 18 are required for carbohydrate utilization). The carbon
source used in our experiments was glycerol, and analysis of genes
involved in glycerol transport and utilization allowed us to con-
struct a metabolic pathway for glycerol metabolism in M. smeg-
matis (Fig. 2). The transcript levels for two transporters of glyc-
erol, MSMEG_6758 (annotated as glpF) and MSMEG_2124
(annotated as a glycerol uptake facilitator) decreased 1.71- and
2.73-fold, respectively. Moreover, the transcript levels that are in-
volved in aerobic utilization of glycerol also decreased (1.50-
fold). These genes include MSMEG_6759 annotated as a putative
glycerol kinase (glpK) and MSMEG_6761 encoding glycerol-3-
phosphate dehydrogenase (glpD2), which leads to the production
of dihydroxyacetone phosphate (DHA-P) (Fig. 2, pathway 1). Ho-
mologues to genes of known phosphotransferase (PTS) systems
were identified in the genome of M. smegmatis (57). The above-
mentioned glycerol uptake facilitator (dhaF [MSMEG_2124]) ap-
pears in an operon with associated dhaMLK genes (MSMEG_2121
to MSMEG_2123), which were suggested to be components of a
PTS system responsible for transport of dihydroxyacetone (DHA)
(59) (Fig. 2). M. smegmatis cannot grow on DHA as the sole car-
bon and energy source, which suggests that dhaF (MSMEG_2124)
could be an efflux mechanism for DHA (Fig. 2). Alternatively,
DhaF could act as a glycerol transporter and the dhaKLM gene
products act as a second pathway for glycerol metabolism as they
do in organisms such as Klebsiella pneumoniae, Clostridium bu-
tyricum, and Citrobacter freundii (19, 20, 27) and more recently E.
coli (15, 26). In this two-branch pathway, glycerol is dehydroge-
FIG 1 (A) Detection of VapC conditional expression over time. A time course
study of VapC protein expression was performed using M. smegmatis vapBC
deletion mutant containing the tetracycline-inducible construct pMind-vapC.
VapC expression was induced with 20 ng ml1 tetracycline, and protein sam-
ples were taken over time at 0, 30, 60, 90, 120, 150, and 180 min postinduction
for Western blot analysis. A positive control using purified VapC () was also
included. (B) Validation of microarray analysis with quantitative RT-PCR.
Microarray data were validated by comparing the gene expression changes of
selected genes obtained from microarray analysis with that of qRT-PCR. The
bars represent changes in the mRNA levels in the M. smegmatis vapBC mu-
tant (expressing VapC versus VapBC) for 4 (microarray) or 3 (qRT-PCR)
independent biological replicates, and the error bars represent standard devi-
ations. Gene expression was normalized to sigA before the transcription levels
in the vapBC deletion strain expressing VapC was compared with that of
VapBC. With the exception of MSMEG_4182 and MSMEG_0515, the values
of gene expression from qRT-PCR were statistically significant (, P value 
0.05; , P value  0.005). CRP, cyclic AMP receptor protein.
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changea P value Descriptionb
Fructose MSMEG_0084 ptsH 1.28 4.97E02 Phosphocarrier protein hpr
MSMEG_0085 fruA 1.37 2.74E02 PTS system, Fru family protein, IIABC components
MSMEG_0086 fruK 1.24 1.35E01 1-Phosphofructokinase
MSMEG_0087 fruR 1.06 3.34E01 Glucitol operon repressor
MSMEG_0088 ptsI 1.81 2.11E03 Phosphoenolpyruvate-protein phosphotransferase
Glycerol MSMEG_1542 1.23 2.60E02 Transcriptional regulator
MSMEG_1543 2.18 4.70E03 EPTC-inducible aldehyde dehydrogenase
MSMEG_1544 1.35 2.08E01 PduO protein
MSMEG_1545 1.12 1.50E01 Conserved hypothetical protein
MSMEG_1546 1.98 1.30E03 Coenzyme B12-dependent glycerol dehydrogenase small subunit
MSMEG_1547 2.02 2.14E03 Glycerol dehydratase large subunit
MSMEG_1548 1.97 1.01E02 Propanediol utilization: dehydratase, medium subunit
MSMEG_1549 1.68 1.56E02 Glycerol dehydratase reactivation factor large subunit; this gene contains a
frameshift which is not the result of sequencing error
Xylose MSMEG_1704 xylF2 1.63 2.66E02 ABC transporter
MSMEG_1705 xylG2 1.47 2.52E02 D-Xylose transport ATP-binding protein XylG
MSMEG_1706 xylH2 1.41 1.76E02 Xylose transport system permease protein XylH
Arabinose MSMEG_1707 pho (1.23) 7.29E02 Phosphatase YfbT
MSMEG_1708 araR 1.0 7.60E01 Ribose operon repressor, putative
MSMEG_1709 araG 1.07 7.50E01 Inner membrane ABC transporter permease protein YjfF
MSMEG_1710 araF 1.27 6.67E02 Ribose transport system permease protein RbsC
MSMEG_1711 araK 1.85 3.03E02 ATP-binding protein of ABC transporter
MSMEG_1712 araE 3.28 8.23E04 ABC transporter periplasmic binding protein YtfQ
MSMEG_1713 araB 1.39 3.19E01 L-Ribulokinase
MSMEG_1714 araD 1.30 1.84E01 L-Ribulose-5-phosphate 4-epimerase UlaF
MSMEG_1715 araA 1.48 1.80E01 L-Ribulose-5-phosphate 4-epimerase UlaF
Glucose, trehalose,
N-acetylglucosamine
MSMEG_2114 1.25 1.57E02 Glucose-6-phosphate isomerase, putative
MSMEG_2115 (1.11) 6.32E01 Conserved hypothetical protein
MSMEG_2116 ptsG 1.33 1.21E02 PTS system, glucose-specific IIBC component
MSMEG_2117 crr 1.32 2.54E02 b-Glucoside-specific EII permease
MSMEG_2118 nagB2 1.37 3.29E02 Glucosamine-6-phosphate isomerase
MSMEG_2119 nagA 1.38 1.07E02 N-Acetylglucosamine-6-phosphate deacetylase
MSMEG_2120 pstR (1.16) 3.51E01 Tetratricopeptide repeat family protein
Dihydroxyacetone MSMEG_2121 ptsT 2.13 3.74E04 Multiphosphoryl transfer protein (MTP)
MSMEG_2122 dhaL 1.96 2.03E03 Dihydroxyacetone kinase, L subunit
MSMEG_2123 dhaK 2.21 6.61E05 Dihydroxyacetone kinase, DhaK subunit
MSMEG_2124 dhaF 2.73 6.19E04 Glycerol uptake facilitator, MIP channel
MSMEG_2125 dhaR 1.02 5.76E01 Glycerol operon regulatory protein
Ribose, ribonucleosides MSMEG_3089 deoC 1.06 6.80E01 Deoxyribose-phosphate aldolase
MSMEG_3090 rbsC2 1.75 1.54E02 Ribose transport permease protein RbsC
MSMEG_3091 rbsA2 1.03 8.12E01 Ribose transport ATP-binding protein RbsA
MSMEG_3092 rbsR2 (2.08) 5.16E01 Transcriptional regulator, sugar-binding family protein
MSMEG_3093 sugK 1.15 5.30E01 Putative sugar kinase protein
MSMEG_3094 sugD 1.58 4.08E02 Oxidoreductase, zinc-binding dehydrogenase family protein
MSMEG_3095 rbsB2 1.80 2.30E03 D-Ribose-binding periplasmic protein
Unknown MSMEG_3264 abcR 1.07 3.92E01 Transcriptional regulator
MSMEG_3265 sugK 1.38 3.32E03 Arabitol-phosphate dehydrogenase
MSMEG_3266 abcE 1.42 1.78E02 Maltose/maltodextrin-binding protein
MSMEG_3267 abcF 1.69 4.34E02 Transporter
MSMEG_3268 abcG 1.19 5.50E02 ABC transporter, permease protein
MSMEG_3269 abcK1 1.69 1.58E02 Putative sugar ABC transporter ATP-binding protein
MSMEG_3270 abcK2 1.26 2.10E01 sn-Glycerol-3-phosphate ABC transporter, ATP-binding protein
MSMEG_3271 sugK 1.24 2.90E01 Dihydroxyacetone kinase
(Continued on following page)
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changea P value Descriptionb
Ribose MSMEG_3598 rbsB3 1.28 4.65E03 Periplasmic sugar-binding proteins
MSMEG_3599 rbsR3 1.42 1.01E02 Sugar-binding transcriptional regulator, LacI family protein
MSMEG_3600 (1.02) 7.80E01 Hypothetical protein
MSMEG_3601 rbsC3 1.53 6.94E03 Ribose/xylose/arabinose/galactoside ABC-type transport systems,
permease components
MSMEG_3602 rbsA3 1.22 2.29E01 Ribose transport ATP-binding protein RbsA
MSMEG_4170 rbsA4 (1.08) 5.15E01 Ribose transport ATP-binding protein RbsA
MSMEG_4171 rbsC4 1.21 2.61E01 Ribose transport system permease protein RbsC
MSMEG_4172 rbsB4 1.46 3.36E02 D-Ribose-binding periplasmic protein RbsB
MSMEG_4173 rbsR4 (1.13) 1.63E01 MaoC family protein
Unknown sugar MSMEG_4655 (1.19) 1.89E01 Transcriptional regulator, AraC family protein
MSMEG_4656 1.37 9.08E03 Sugar ABC transporter ATP-binding protein
MSMEG_4657 1.42 1.60E02 ABC transporter membrane protein
MSMEG_4658 1.49 4.33E04 Sugar ABC transporter substrate-binding protein
MSMEG_4659 1.02 6.77E01 GntR family protein transcriptional regulator
MSMEG_4660 1.14 3.38E01 Hypothetical protein
MSMEG_4661 1.47 1.02E02 Sugar kinase, ribokinase family protein
MSMEG_4662 1.27 1.67E01 Deoxyribose-phosphate aldolase superfamily protein
MSMEG_4663 iolB 1.78 1.88E03 IolB protein
MSMEG_4664 iolD 1.53 4.17E02 IolD protein
MSMEG_4665 iolE 1.30 4.81E03 IolE protein
MSMEG_4666 1.06 8.33E01 myo-Inositol 2-dehydrogenase
MSMEG_5057 1.36 1.46E03 Conserved hypothetical protein
MSMEG_5058 sugK 1.52 4.32E04 ABC transporter, ATP-binding protein SugC
MSMEG_5059 sugG 1.46 8.71E05 ABC transporter, permease protein SugB
MSMEG_5060 sugF 1.37 1.24E04 ABC transporter, permease protein SugA
MSMEG_5061 sugE 1.30 2.96E04 Bacterial extracellular solute-binding protein
MSMEG_5062 1.11 1.62E02 Conserved hypothetical protein
Succinate MSMEG_5302 dctA 1.73 2.57E02 Aerobic C4-dicarboxylate transport protein
Sugar alcohol MSMEG_5571 smoK 1.80 3.06E03 ABC transporter ATP-binding protein
MSMEG_5572 smoG 1.76 1.37E02 Sugar ABC transporter permease protein
MSMEG_5573 smoF 1.99 2.01E02 Sugar ABC transporter permease protein
MSMEG_5574 somE 1.92 1.20E03 Substrate-binding protein
MSMEG_5575 smoR 1.68 2.30E03 Repressor
Xylose MSMEG_6018 xylG1 1.60 2.39E02 Xylose transport permease protein XylH
MSMEG_6019 xylF1 (1.20) 7.50E01 ABC-type sugar transport system ATPase component
MSMEG_6020 xylE1 1.11 5.15E01 D-Xylose-binding periplasmic protein
MSMEG_6021 xylA1 1.65 2.57E02 Xylose isomerase
MSMEG_6022 xylR1 (1.08) 3.13E01 Xylose repressor, ROK family protein transcriptional regulator
Glycerol MSMEG_6238 1.70 3.49E02 Putative two-component system sensor kinase
MSMEG_6239 1.77 1.44E02 1,3-Propanediol dehydrogenase
MSMEG_6240 1.44 1.84E01 Conserved hypothetical protein
MSMEG_6241 1.73 1.15E01 ATPase associated with various cellular activities
MSMEG_6242 2.02 3.94E02 Alcohol dehydrogenase containing iron
MSMEG_6243 1.27 4.33E02 Response regulator receiver domain protein
MSMEG_6756 glpK2 1.19 1.88E02 Glycerol kinase
MSMEG_6757 glpR 1.47 5.86E04 Glycerol operon regulatory protein
MSMEG_6758 glpF 1.71 2.11E04 Transport integral membrane protein
MSMEG_6759 glpK1 2.10 8.12E04 Glycerol kinase
MSMEG_6760 glpD 1.13 9.60E01 Conserved hypothetical protein
MSMEG_6761 glpD2 2.10 7.42E04 Glycerol-3-phosphate dehydrogenase 2
Ribose MSMEG_6802 (1.18) 7.28E01 ABC transporter ATP-binding protein
MSMEG_6803 1.41 4.11E02 Ribose transport system permease protein RbsC
MSMEG_6804 1.45 5.03E03 Sugar ABC transporter substrate-binding protein
a Boldface values indicate a downregulation of 1.5-fold or greater in gene expression. Shading indicates significant fold changes with P value of 0.05. The values in parentheses are
upregulated genes.
b PTS, phosphotransferase; EPTC, S-ethyl dipropylcarbamothioate; EII, enzyme II; MIP, major intrinsic protein family.
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nated to DHA, which is then phosphorylated to DHA-P via DHA
kinase (dhaKLM), as well as being dehydrated by a coenzyme B12-
dependent glycerol dehydratase enzyme to form 3-hydroxypropi-
onaldehyde (3-HPA) followed by reduction via 1,3-propanediol
dehydrogenase to generate propanediol by-products (20, 21, 29).
The transcripts encoding enzymes associated with the reductive
branch of a putative anaerobic glycerol pathway in M. smegmatis,
i.e., glycerol dehydratases, MSMEG_1546 to MSMEG_1549, were
also downregulated 2-fold (Fig. 2, pathway 2). Analysis of the
amino acid sequences for MSMEG_1546 and MSMEG_1547 sug-
gested that these proteins were homologues of DhaB subunits
from K. pneumoniae (BLAST analysis indicated 50 to 65%
identity and 70 to 80% positive results). Other carbon transport
gene transcripts that were decreased belong to the ATP binding cassette
(ABC) family whose substrates include xylose (MSMEG_1704 and
MSMEG_6018),arabinose(MSMEG_1711andMSMEG_1712), ribose
(MSMEG_3090, -3095, and -3601), sugar alcohol (MSMEG_5571 to
-5574)aswellasotherunknownsugarsubstrates(MSMEG_3267,-3269,
and -5058) (Table 2).
In response to VapC expression, genes involved in transport
and scavenging of phosphate were upregulated (see Table S2 in the
supplemental material). Genes belonging to the high-affinity
phosphate-specific transport systems PstSCAB and PhnDCE in
M. smegmatis were upregulated (1.71-, 1.85-, and 1.68-fold for
pstS, pstC, and phnD transcripts, respectively) (23, 25). Also up-
regulated 1.67-fold was the gene that encodes the PitA low-affinity
phosphate transporter (24).
VapC is a sequence-specific RNase that targets AUAU and
AUAA sites. The microarray data suggested that VapC was target-
ing specific mRNA transcripts involved in carbon transport and
metabolism, particularly those involved in glycerol metabolism.
Overexpression of VapC from M. smegmatis for the purposes of
protein purification was unsuccessful due to its toxicity to the cell,
but VapC can be expressed in complex with its VapB antitoxin and
the VapBC protein complex can be purified (51). It is a well-
known feature of toxin-antitoxin systems that the antitoxin is
more susceptible to proteolytic degradation than the toxin (27,
44). Thus, functional VapC was obtained by treating the VapBC
complex with trypsin and digesting the antitoxin VapB. The dif-
ference in the predicted isoelectric points of trypsin (10.5) and
VapC (4.9) enabled separation of the two by anion-exchange
chromatography (see Fig. S1 in the supplemental material).
MALDI MS of purified VapC revealed two different species (16.33
kDa and 14.94 kDa) corresponding to VapC with and without the
C-terminal His tag which is in accordance with the theoretical
molecular masses of both species (16.30 kDa and 14.91 kDa).
There were no MALDI MS peaks for VapB.
VapC from M. smegmatis (MSMEG_1284) belongs to the PIN-
domain superfamily (NCBI annotation, PilT-domain-containing
protein; Pfam number PF01850), which contains 4,089 proteins
from 1,139 different species across the three domains of life (19).
PIN-domain proteins are small (130 amino acids) and are char-
acterized by three strictly conserved acidic residues proposed to
constitute the active site. VapC from M. smegmatis contains these
three acidic residues (Asp4, Asp99, and Glu118). Biochemically,
the PIN-domain proteins are ribonucleases; in prokaryotes, they
are typically found as the toxic member of toxin-antitoxin sys-
tems, and in eukaryotes, they are associated with nonsense-medi-
ated decay (NMD) of RNA (58) and preprocessing of rRNA (39).
VapC from H. influenzae, Shigella flexneri 2a, and Salmonella en-
terica and five VapC proteins from M. tuberculosis display RNase
activity (1, 14, 44, 50). To assess RNase activity of VapC from M.
smegmatis, we produced RNA from a set of 12 plasmids whose
overlapping inserts encode every combination of five bases. Col-
lectively, these are called pentaprobes; the first six plasmids (922 to
927) contain sequences in the forward direction, and the last six
(928 to 933) contain the reverse complement sequences (i.e., 928
is the reverse complement to 922) (38). RNA was transcribed from
a PCR product including a T7 promoter at the 5= end of the pen-
taprobe insert. Each pentaprobe RNA was incubated in vitro with
purified VapC at 37°C in an assay buffer containing 6 mM MgCl2
at pH 7.4. Negative controls included either EDTA (as PIN-do-
mains are Mg2/Mn2-dependent ribonucleases) or VapBC or no
VapC (to ensure RNase activity was not due to contaminating
ribonucleases). VapC degraded RNA pentaprobes 925, 926, 927,
and 932 but did not degrade pentaprobes 922, 923, and 924 (Fig.
3A shows pentaprobes 924, 925, and 932; for other pentaprobes
FIG 2 VapC regulation of the major glycerol-utilizing pathways identified in
M. smegmatis. The schematic diagram indicates the glycerol-utilizing path-
ways present in M. smegmatis. The numbers in red represent gene expression
ratios determined by microarray analysis in response to VapC expression. The
black numbers represent gene expression ratios of selected genes involved in
glycerol metabolism obtained through comparison of vapBC deletion mu-
tant mRNA levels with M. smegmatis mc2155 as determined by qRT-PCR (see
Fig. 8). Two pathways for glycerol metabolism are represented and have been
assembled based on putative roles for genes annotated in M. smegmatis ge-
nome. Pathway 1 indicates glycerol utilization mediated by an ATP-dependent
glycerol kinase and a glycerol dehydrogenase. A second pathway (pathway 2)
requires a glycerol dehydrogenase and dihydroxyacetone kinase to convert
glycerol to dihydroxyacetone phosphate (DHA-P). A parallel branch in path-
way 2 dehydrates glycerol by a coenzyme B12-dependent glycerol dehydratase
to synthesize propanediol derivatives. The genes and the proteins they encode
are as follows: glpF, glycerol uptake facilitator; glpK, glycerol kinase; glpD,
glycerol-3-phosphate dehydrogenase; dhaF, glycerol uptake facilitator;
dhaKLM, DHA kinase; dhaB, glycerol dehydratase; dhaT, NADH-dependent
1,3-propanediol dehydrogenase. Abbreviations: G-3-P, glycerol-3-phosphate;
DHA, dihydroxyacetone; 3- and 2-HPA, 3- and 2-hydroxypropionaldehyde;
TCA, tricarboxylic acid cycle. All gene expression ratios shown for individual
genes are statistically significant (P value of 0.05), with the exception of glpF
qRT-PCR value 1.58 (P value of 0.17). The average gene expression ratios of
the 4 downregulated genes (MSMEG_1546 to MSMEG_1549) are shown for
dhaB.
McKenzie et al.
2196 jb.asm.org Journal of Bacteriology







tested, see Fig. S2 in the supplemental material). Different frag-
mentation patterns were observed on urea-denaturing polyacryl-
amide gels corresponding to different pentaprobe RNAs (Fig. 3A).
Based on these data, VapC is a sequence-specific Mg2-dependent
RNase, as demonstrated by its abilities to cleave a subset of pen-
taprobe RNAs and show differing fragmentation patterns for the
different pentaprobe RNA substrates. Inclusion of EDTA in the
reaction mixture inhibited VapC activity consistent with a Mg2-
dependent RNase (Fig. 3A). The VapC from M. smegmatis also
appears to not only cleave RNA but also to bind RNA and suggests
that binding and cleavage are separable properties, and this war-
rants further investigation given the fact that VapCs (i.e., Rv0065
and Rv0617) from M. tuberculosis do not show this RNA binding
property (1). VapC cleaves pentaprobe 932 RNA most efficiently
and demonstrates no nuclease activity against its single-stranded
DNA (ssDNA), dsDNA, and dsRNA equivalents (Fig. 3B). Sec-
ondary structures in the dsRNA are present (Fig. 3B, dsRNA, top
band) that VapC appears to bind to, as shown by the disappear-
ance of the top band and a slight shift in the bottom band upon the
addition of VapC. Intriguingly, the cleavage of the 932 RNA sub-
strate is far more efficient than cleavage of corresponding short
oligonucleotides, and this suggests that additional features such as
RNA secondary structure play a role in VapC-mediated mRNA
degradation.
To determine the sequence specificity of VapC, short overlap-
ping RNA oligonucleotides were designed to cover the sequence of
the parent 932 pentaprobe RNA substrate. VapC cleaves four of
the nine short RNA oligonucleotides, and MALDI MS was used to
identify the VapC cleavage sites in three of the four short oligonu-
cleotides (Fig. 4A). VapC cleaves RNA oligonucleotides at AUAA
and AUAU sequences yielding a 5= phosphate on the 3= cleavage
product. Less efficient cleavage at other sites (for example GAUG)
was also observed (Fig. 4B and C). Three bases on either side of the
cleavage sites in 932 RNA oligonucleotides 3, 4, and 5 were ana-
lyzed using the online program WebLogo (13), and the VapC
consensus sequence was determined (Fig. 4C). Thus, the optimal
sequences for VapC cleavage from M. smegmatis is AUAU and
AUAA leaving a 5= phosphate on the 3= cleavage product consis-
tent with a metal-dependent RNase (2). The “wobble” in the target
sequence indicates that other “suboptimal” sequences will also be
cleaved by VapC (albeit much less efficiently). Indeed, it is likely
that the optimal substrate is a combination of the target sequence
with a particular RNA secondary structure.
VapC cleaves RNA transcripts in vitro that are downregu-
lated by VapC expression in vivo. A cohort of genes downregu-
lated in response to conditional VapC expression in the M. smeg-
matis vapBC mutant were identified by microarray analysis in
Table S2 in the supplemental material). An annotated operon
encoding genes involved in glycerol uptake and metabolism
(MSMEG_2124, -2123, -2122, and -2121) (Fig. 2) included the
ATAA target sequence in the 5=UTR of MSMEG_2124 and the
ATAT target sequence in the 3= end of MSMEG_2121, the last
gene in the operon. All genes in this operon were downregulated
in response to overexpression of VapC (Table 2), suggesting that
the operon mRNA is destabilized by cleavage at each end, resulting
in degradation of the entire mRNA. Reverse transcriptase PCR
(RT-PCR) confirmed that the 5=UTR for the operon included the
ATAA target sequence 95 bases upstream of the MSMEG_2124
start codon (data not shown). The genes encoding MSMEG_2124
(with and without the 5=UTR), MSMEG_2123, MSMEG_2122, and
MSMEG_2121 were PCR amplified, and the addition of a T7 pro-
moter to the 5= end allowed for production of the RNA transcript for
each gene (Fig. 5). The gene encoding MSMEG_0650 (phnF) that
exhibited no change in the microarray data (Table S2) and does
not contain the cleavage site was also transcribed to produce
mRNA. VapC shows RNase activity against MSMEG_2121
FIG 3 In vitro RNase activity of VapC. (A) VapC displays sequence-specific RNase activity against pentaprobe RNA molecules 925 and 932 but not 924 in the
presence of 6 mM MgCl2. Negative controls show no nonspecific degradation of RNA due to contaminating ribonucleases and include the following: RNA-only
controls (VapC) and EDTA, addition of 12 mM EDTA to the assay reaction mixture and VapBC, and the addition of purified VapBC complex instead of VapC
to the assay reaction mixture. The addition of VapC (VapC) results in degradation of the 925 and 932 pentaprobe RNA molecules over a period of 5 to 60 min
(time indicated in minutes across the top of gels) but not the 924 RNA molecule, indicating that VapC is a sequence-specific RNase. A molecular size marker at
the left side of the gel shows molecular sizes of single-stranded RNA (ssRNA) in bases. (B) VapC does not cleave dsDNA, ssDNA, or dsRNA. VapC does not cleave
932 dsRNA, 927 ssDNA, or 927 dsDNA (VapC) but cleaves ssRNA of the same sequence. Negative controls (VapC) show no nuclease contamination.
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mRNA in vitro and to a lesser extent toward MSMEG_2124 that
includes the 5=UTR (Fig. 5). Removal of the MSMEG_2124
5=UTR that includes the ATAA cut site greatly reduces the
RNase activity of VapC against this transcript, indicating that
VapC is cleaving at ATAA. Other transcripts in the operon that
do not contain the cut site exhibit a small amount of RNA
degradation by VapC (RNA transcripts MSMEG_2122 and
MSMEG_2123 due to cleavage of suboptimal sequences) (Fig. 5).
The RNase activity of VapC was higher against these biologically
relevant substrates (M. smegmatis mRNA transcripts) compared
to the synthetic pentaprobe RNAs tested above (61.35 pmol
of VapC was used in the pentaprobe assays, whereas 1.23 pmol of
VapC was used in the M. smegmatis mRNA transcript assays).
VapC does not cleave MSMEG_0650, suggesting that VapC is di-
rectly targeting the downregulated transcripts by cleaving at
AUAA or AUAU sites (Fig. 5, bottom panel) to destabilize the
mRNA, resulting in its degradation and subsequent downregula-
tion of all genes in the operon. This mechanism of mRNA desta-
bilization by cleavage at 5= and 3= ends has been well studied in E.
coli and Bacillus subtilis (11, 37). In addition, VapC displayed no
activity against tRNAfMet (MSMEG_1965) from M. smegmatis at
high (61.35 pmol) and low (1.23 pmol) concentrations of VapC
(see Fig. S3 in the supplemental material). The VapC cut site
AUAA is present in tRNAfMet but is not cut, strengthening the idea
that the optimal substrate is a combination of sequence and RNA
secondary structure.
Optimal mRNA substrate for M. smegmatis VapC. The ex-
perimental data for RNA cleavage by VapC pointed strongly to the
involvement of RNA secondary structure contributing to the
VapC recognition motif. We took the three substrates that had
been experimentally shown to be efficiently cut by M. smegmatis
VapC and used the local RNA prediction algorithm RNALfold to
look for secondary structures associated with the three experi-
mentally cut sequences (32). All three RNA substrates showed a
predicted stable hairpin immediately downstream of the
AUA(U/A) sequence (Fig. 6A). Following manual alignment of
these three sequences along with their secondary structure motifs,
we built a covariance model (CM) (46). CMs are probabilistic
models that can be used to score related sequences incorporating
both sequence and structure similarity. By using independent
benchmarks, the accuracy of CMs is greater than alternative meth-
ods (22). The substrate CM was then used to search 39 genes and
flanking sequences [containing 62 AUA(U/A) sites] for analogous
motifs. The high-scoring matches to this CM were incorporated
into the alignment. The alignment and consensus secondary
structure were manually refined, and the CM was then rebuilt and
researched against the 39 genes. This process was iterated for sev-
eral cycles until no further high-scoring matches were found. The
resulting annotated, consensus structure is shown in Fig. 6B.
This refined CM model was then tested against several sets
of RNA sequences: genes downregulated in response to VapC
and genes upregulated in response to VapC and shuffled con-
trol sequences for each set. The distribution of CM bit-scores
shows a significant difference in the downregulated operon
sequences versus the two different control sets of operons con-
taining upregulated genes and shuffled control sequences (Fig.
6C). A two-sample Kolmogorov-Smirnov test of the scores
from the downregulated operons gives a P value of 6.631E05.
We also tested whether the M. smegmatis tRNAs contained
matches to the CM. We found that in contrast to earlier work
(62), the tRNAs were deficient in predicted VapC targets rela-
tive to shuffled control sequences. This predicted RNA motif of
-AUAW-hairpin-G- sheds light on previously observed cleav-
age patterns for a range of substrates tested in the laboratory
(Fig. 6D). These experimental results add weight to the pre-
dicted optimal substrate for M. smegmatis VapC. The precise
role that each position in the RNA motif plays in efficient cleav-
age is the subject of ongoing work.
VapC is a posttranscriptional regulator of glycerol metabo-
lism in mycobacteria. The microarray and VapC RNA cleavage
assays demonstrated that VapC was targeting mRNA transcripts
involved in glycerol transport and metabolism. We hypothesize
that this could be a mechanism to control the rate of carbon uti-
lization in response to the requirements of the cells (e.g., energy
production to drive anabolic reactions). To test this hypothesis,
the wild type and the vapBC mutant were grown in minimal
medium containing glycerol, and several parameters of energy
FIG 4 VapC from M. smegmatis targets AU-rich sequences. (A) MALDI-TOF
MS spectra for 932 RNA oligonucleotide 3 RNase assay. Negative controls
show no contaminating ribonucleases in the protein preparation (EDTA) or
the assay buffer (VapC). The m/z values for each RNA fragment are shown
above each peak. Identification of VapC cleavage sites (VapC 15, 30, and 60
min) in 932 RNA oligonucleotide 3 are shown in panel B. (B) The 932 RNA
oligonucleotide 3 is shown by colored bases, and the cut sites (arrows) at
AUAU, AUAA, and GAUG are shown with the corresponding m/z values. (C)
Analysis of VapC cleavage sites across 932 RNA oligonucleotides 3, 4, and 5 as
calculated by WebLogo. VapC cleaves after position 3. The height of the letter
is proportional to the frequency of that base at that particular position. The
positions are labeled 1 to 6.
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were measured (glycerol utilization and the molar growth yield on
glycerol). When grown in either LBT (Fig. 7A) or HdB minimal
medium with glycerol (0.2% vol/vol) as the sole carbon source
(Fig. 7B), the vapBC mutant consistently grew faster (2.7 h dou-
bling time) than the wild-type cells (3.2-h doubling time). When
the vapBC mutant was complemented with VapBC, the mutant
grew slower (3.5-h doubling time) than the wild-type cells, dem-
onstrating that VapBC was having an effect on the growth rate of
M. smegmatis (Fig. 7C) and showing an overcompensation of
VapBC levels in the complementing strain. This growth rate phe-
nomenon was subtle, and we had previously discounted its signif-
icance (49). However, we revisited and remeasured these data in
light of the emerging hypothesis herein.
To determine the metabolic basis for this higher growth rate in
the vapBC mutant, we measured the specific rate of glycerol
consumption required for growth by the wild type and vapBC
mutant during early exponential growth (Fig. 8A, time points T1
and T2). The specific rate of glycerol consumption by the vapBC
mutant was 2.4-fold higher (3.4  0.6 mmol glycerol/h/g [dry
weight] cells) than that of the wild type (1.4  0.3 mmol glycerol/
h/g [dry weight] cells) (time point 1), and this was consistent for
two sampling points taken during exponential growth (Fig. 8B).
To determine whether this increased rate of glycerol consumption
was coupled to growth, we measured the molar growth yield on
glycerol (Yglycerol) (Fig. 8C). This analysis revealed that the in-
creased rate of glycerol consumption was not used for generating
bacterial biomass, as the Yglycerol was 76  19 g [dry weight] cells/
mol glycerol utilized, for the vapBC mutant, and it was 182 
FIG 5 VapC cleaves mRNA transcripts in vitro that are downregulated by conditional expression of VapC in vivo. The schematic diagram at the top of the figure
represents the MSMEG_2124 operon downregulated in vivo upon VapC induction. The VapC cut site ATAA is present in a conserved stem-loop in the known
5=UTR, and ATAT is also present in a stem-loop in MSMEG_2121 at the end of the operon (cut sites are labeled and indicated by scissors). VapC displays
sequence-specific RNase activity against MSMEG_2121 and MSMEG_2124 including 5=UTR, but not MSMEG_2123 and MSMEG_2122 in the presence of 6 mM
MgCl2 (time points are indicated along the top of the gels in minutes). MSMEG_0650 does not contain the VapC cut site and is not cleaved by VapC in vitro in
the presence of 6 mM MgCl2 (MSMEG_0650 exhibits no change upon VapC induction in vivo). Negative controls show no nonspecific degradation of RNA due
to contaminating ribonucleases and include RNA-only controls (VapC) and 20 mM EDTA added to the assay reaction. A molecular size marker at the left side
of the gel shows the molecular sizes of ssRNA in bases.
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21 g [dry weight] cells/mol glycerol utilized for the wild type,
suggesting that glycerol consumption was uncoupled from bio-
mass generation in the vapBC mutant (time point 1 [Fig. 8C]).
These data suggest that genes involved in glycerol utilization, con-
trolled by VapC, could be upregulated in a vapBC mutant rela-
tive to the wild type. To test this hypothesis, quantitative RT-PCR
was performed to determine the levels of VapC-targeted mRNA
transcripts in the vapBC mutant compared with the wild-type
M. smegmatis strain mc2155 during exponential growth on glyc-
erol (Fig. 9). Genes involved in glycerol and dihydroxyacetone
metabolism were all significantly upregulated in the vapBC mu-
tant relative to the wild type, which is consistent with this hypoth-
esis (Fig. 9 and summarized in Fig. 2).
DISCUSSION
Efficient growth of a bacterial cell is achieved through the fine-
tuning of anabolic (energy-consuming) and catabolic reactions
(energy-producing) to achieve maximum growth rate and carbon
source utilization (53). This is particularly pertinent to bacterial
cells that inhabit natural environments where nutrients are often
limiting for growth and coupling of substrate utilization to the
production of cells is a major determinant of ecological success. In
the laboratory, bacteria are generally grown with an excess of nu-
trients (carbon and energy rich), and therefore, bacteria may in-
stigate mechanisms to uncouple catabolism from anabolism, en-
abling them to consume the carbon and energy source faster than
FIG 6 Bioinformatic characterization of the VapC target mRNAs. (A) Predicted RNA secondary structures for the 3 experimentally validated VapC
targets found in the MSMEG_2124 5= UTR, MSMEG_2121 mRNA, and the artificial pentaprobe 932 sequence. (B) Consensus model of predicted VapC
targets. (C) Cumulative distribution functions (CDFs) of covariance scores for sequences matching the consensus model (CM). The top panel shows the
operon sequences containing at least one downregulated gene and corresponding controls. The bottom panel shows the distribution of scores matching
tRNA sequences and a shuffled control. The numbers of searched sequences (N) and matches (M) are indicated in the legends. (D) Schematic diagrams
showing the presence or absence of the optimal RNA substrate motif for various RNA substrates (oligo, oligonucleotide). RNase activity was scored for
substrates tested. RNase activity is indicated as follows: , weak activity; , strong activity; X, no activity. Substrates with the predicted optimal
structure are cleaved more efficiently than those with other secondary structures.
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it is required for growth. Such a strategy is exemplified by Esche-
richia coli, which excretes acetate at high rates of glucose con-
sumption even in the presence of high oxygen (60). During
growth on glycerol, mycobacteria are proposed to exhibit unreg-
ulated growth. In both of these cases, the molecular mechanisms
controlling the rate of uncoupling in bacterial growth and the
mechanisms whereby excess energy is spilled remain to be eluci-
dated. For many bacteria, one of the main by-products associated
with unregulated carbon dissimilation is methylglyoxal, a strong
electrophile. Mycobacteria have recently been proposed to pro-
duce methylgloxal and are inhibited by excess sugar phosphates
(36, 48). Based on these observations, mycobacteria must have
evolved control mechanisms that balance the rate of carbon utili-
zation with growth to prevent the buildup of excess sugar phos-
phates and methylgloxal in the cell.
In this communication, we propose a new mechanism for the
control of carbon (sugar) utilization in mycobacteria mediated by
the toxin-antitoxin module VapBC. When VapC, a RNase, was
overexpressed in Mycobacterium smegmatis, the transcriptional
response suggested that VapC was targeting (downregulating)
specific mRNA transcripts involved in carbon transport and me-
tabolism, particularly those involved in glycerol metabolism. In
response to VapC overexpression, we also observed a number of
upregulated genes involved in phosphate uptake. When bacterial
cells have an excess of sugar phosphates, methylgloxal is pro-
duced, leading to a release of phosphate. Indeed, methylgloxal
production has been proposed as a mechanism to replenish intra-
cellular phosphate. These observations suggest a potential link
between VapC and phosphate: if VapC downregulates sugar me-
tabolism and hence sugar phosphates do not accumulate, the my-
cobacterial cell may upregulate phosphate transporters to com-
pensate for this apparent phosphate limitation.
Mycobacteria are generally cultured using glycerol as the stan-
dard carbon source, but detailed knowledge on the biochemical
processes associated with glycerol uptake, metabolism, and regu-
lation are poorly understood (47, 48). Beste et al. (7) have reported
that glycerol kinase is essential for growth of M. tuberculosis in
minimal medium containing glycerol, giving validity to the path-
FIG 7 Comparison of growth of the wild-type M. smegmatis mc2155 and
vapBC deletion mutant. (A and B) Comparative growth analysis of wild-type
M. smegmatis mc2155 and vapBC deletion strain were performed using rich
medium LBT (A) and minimal medium HdB containing 0.2% glycerol (B).
Growth was determined by optical density at 600 nm over time (hours). (C)
Complementation of the vapBC mutant was performed using tetracycline-
inducible pMind_vapBC construct. For complementation, empty vector
(pMind) controls were used in the wild-type mc2155 strain and the vapBC
deletion mutant. Complementation was performed in HdB medium contain-
ing 0.2% glycerol. Results for all growth experiments are from three biological
replicates, and the error bars represent standard deviations.
FIG 8 Comparative analysis of glycerol consumption and molar growth yield
on glycerol for the wild type and the vapBC mutant. (A) Supernatant samples
and dry weights were taken for strain mc2155 (wild type) and the vapBC
deletion mutant at two time points during the early stages of growth (T1 and
T2). (B) Specific rate of glycerol consumption (mmol glycerol consumed/h/g
[dry weight] cells). (C) Molar growth yield on glycerol (Yglycerol) (g [dry
weight] cells/mol glycerol utilized) was calculated for each strain. The glycerol
consumption rate and Yglycerol were determined for three replicate samples,
and the error bars represent standard deviations.
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way proposed in Fig. 2. On the basis of our microarray analysis, we
propose that M. smegmatis has two pathways for the utilization of
glycerol (Fig. 2). We base this scheme on the following observa-
tions; aerobic bacteria generally utilize a glycerol metabolic path-
way that involves an ATP-dependent glycerol kinase and glycerol
3-phosphate dehydrogenases (16). This pathway was downregu-
lated in M. smegmatis along with an associated glycerol facilitator
in response to VapC overexpression. A second pathway for glyc-
erol metabolism has been reported to operate in E. coli under
fermentative (microaerobic) conditions (16, 28) and uses a type II
glycerol dehydrogenase and dihydroxyacetone kinase (DhaKLM)
to synthesize dihydroxyacetone phosphate. We could not identify
a type II glycerol dehydrogenase homologue, but dhaKLM is pres-
ent (Fig. 2). We were able to identify a number of genes that were
downregulated in response to VapC, which fed into pathways leading
to the production of dihydroxyacetone phosphate, the major source
of the toxic intermediate for methylglyoxal synthesis.
To test the role of VapC-mediated regulation of glycerol me-
tabolism in vivo, we measured the kinetics and energetics of glyc-
erol utilization by the wild type and an isogenic vapBC mutant.
We rationalized that a vapBC mutant should consume glycerol
at a higher rate than wild-type cells, and because of this faster
utilization rate, uncoupled growth would occur, leading to an
overall lower molar growth yield on glycerol. Moreover, genes
involved in glycerol utilization should be upregulated in a vapBC
mutant relative to the wild type. Both predictions were validated
experimentally with glycerol-grown cells in batch culture and
qPCR showing that in the vapBC mutant, the levels of transcripts
involved in glycerol utilization were indeed elevated during
growth on glycerol compared to transcript levels in the wild type.
In support of this model, we demonstrated that purified VapC
cleaved the dhaKLM operon in vitro, and we identified the specific
RNA motif that is the target of VapC RNase activity. We propose
that VapBC provides the cell with an elegant mechanism to regu-
late sugar metabolism in M. smegmatis by targeting specific genes
at a posttranscriptional level involved in carbon source utilization
in response to the anabolic demands of the cell (e.g., fast or slow
growth), thus acting as a link between energy-producing and en-
ergy-consuming reactions in the cell. The targeting of mRNA al-
lows the cell to fine-tune its rate of glycerol utilization without the
need for complicated transcriptional scenarios allowing for rapid
adjustments of catabolic flux to prevent toxic intermediates accu-
mulating. The question remained as to what the cells do with the
glycerol consumption that is in excess of growth requirements? At
this point, we can only speculate that this could be associated with
either increased ATP production and spilling by a futile cycle
and/or directed into storage compounds (53). In vitro RNase ac-
tivity has been reported for VapC proteins previously (1, 14, 44,
50). Two recent papers have connected this biochemical activity to
a biological response in diverse microorganisms. vapBC6 from
Sulfolobus solfataricus has been shown to be upregulated in re-
sponse to heat shock, and the RNase activity of VapC6 was shown
to directly target transcripts encoding oligopeptide permease
(dppB-1) and a tetR transcription factor (40). VapCs from the
enteric bacteria Shigella flexneri and Salmonella enterica have also
been shown to be sequence-specific RNases cleaving initiator
tRNA at the anticodon stem-loop and thus inhibiting translation
(62). These results are consistent with our findings for VapC in M.
smegmatis insofar as the RNase activity of VapC targets specific
RNA substrates in vivo. Our data show that VapC in M. smegmatis
is a posttranscriptional regulator of carbon metabolism, whereas
the data from the enteric bacteria suggest a role for VapC in the
global control of translation. These alternative hypotheses are
compatible, as there is no expectation that the biochemical RNase
activity of VapC should play equivalent roles in bacteria from such
diverse branches of the prokaryotic tree.
The results presented here rule out tRNA as the target for M.
smegmatis VapC. The optimal target sequence for M. smegmatis
VapC is a sequence and structure motif characterized by an
AUA(U/A) head, a short 3= RNA hairpin, followed by a G tail. This
is present in 75% (45/60 operons) of the operons containing
downregulated genes and is not present in tRNA (Fig. 8C). The
results of our in vitro assays presented here and previously (1)
show that the VapC RNases target these optimal sites with fast
kinetics (1 min). However, under conditions where VapC is at
relatively high concentrations, suboptimal sites will be cleaved
with slow kinetics (over 5 to 60 min). In a biological setting where
the vapBC operon is constitutively expressed at very low levels
(51), only the optimal target sites (with inherently fast cleavage
kinetics) will be relevant.
The general mechanism for mRNA degradation in mycobac-
teria has not been well studied; however, it has been well charac-
terized in E. coli (37) and Bacillus subtilis (11). A major determi-
nant of mRNA stability in both organisms is the 5=UTR and 3= end
of the transcript (9, 11). These transcript ends often contain stem-
loops and other secondary structures that provide a barrier to
exoribonuclease degradation (57). Many genes downregulated by
VapC include the target sequence in the 5=UTR region and/or the
3= end of the transcript. Where whole operons are downregulated,
the target sequences are often found in the first and last genes of
the operon (e.g., MSMEG_2124 to MSMEG_2121). The propen-
sity for VapC from M. smegmatis to target a combination of sec-
ondary structure and specific sequences at 5= and 3= transcript
ends adds validity to our hypothesis.
FIG 9 Comparison of VapC-targeted mRNA transcripts in M. smegmatis
mc2155 and the vapBC deletion strain. Quantitative RT-PCR was performed
to determine the levels of VapC-targeted mRNA transcripts in the vapBC
mutant compared with the wild-type M. smegmatis strain mc2155. The cells
were grown to an OD600 of 0.1 in batch culture in HdB medium containing
0.2% glycerol and then harvested for RNA extraction. Differential gene expres-
sion changes between the vapBC mutant and mc2155 were determined (, P
value of 0.05; , P value of 0.005). Error bars represent standard devia-
tions from three biological replicates.
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M. smegmatis harbors a single VapBC module, whereas slowly
growing M. tuberculosis harbors 45 vapBC TA systems with very
few sugar transporters (59). No glycerol-specific uptake systems
have been identified in M. tuberculosis, and it has been suggested
that facilitated diffusion of glycerol might be sufficient given the
low growth rate (47). This suggests that M. tuberculosis has no
mechanism for regulating sugar metabolism at the level of trans-
port, and therefore, tighter control of catabolic pathways might be
required. Recent work has shown that M. tuberculosis does not
exhibit substrate preferences, i.e., they are able to cometabolize
several substrates simultaneously (15). This is achieved by a com-
partmentalized scheme for metabolism, and therefore, the need
for more than one VapBC module may be anticipated. The genetic
requirement in M. tuberculosis for two putative VapC proteins
(Rv2103c and Rv2494) for strain fitness at a low growth rate and
an antitoxin gene (Rv0596c) for fitness at a high growth rate (7)
lend support to this argument and show obvious routes to testing
VapC-mediated regulation and its biological consequences in M.
tuberculosis.
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